Systematic Review
Published on 01 Nov 2024
Thematic trends and knowledge-map of tumor-infiltrating lymphocytes in breast cancer: a scientometric analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1438091
- 582 views
- Frontiers in Oncology
- Breast Cancer
- Articles
Type at least 3 characters
1,229 articles
Articles
Original Research
Published on 01 Nov 2024
The role of systemic immune-inflammation index in predicting pathological complete response of breast cancer after neoadjuvant therapy and the establishment of related predictive model
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1437140
- 503 views
Case Report
Accepted on 31 Oct 2024
Palinopsia associated to the CDK4/6 inhibitor ribociclib during the first-line treatment of metastatic breast cancer: two case reports
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1430341
Review
Published on 31 Oct 2024
Mechanisms of endocrine resistance in hormone receptor-positive breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1448687
- 567 views
Original Research
Published on 29 Oct 2024
Factors affecting lymphedema after neoadjuvant chemotherapy and axillary dissection in female breast cancer patients: a retrospective cohort study based on the Chinese population
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1436748
- 406 views
Systematic Review
Published on 28 Oct 2024
The effects of Tai Chi and Baduanjin on breast cancer patients: systematic review and meta-analysis of randomized controlled trials
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1434087
- 517 views
Original Research
Published on 25 Oct 2024
Clinical-radiomics nomogram based on the fat-suppressed T2 sequence for differentiating luminal and non-luminal breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1451414
- 383 views
Review
Published on 25 Oct 2024
Obesity and lack of breastfeeding: a perfect storm to augment risk of breast cancer?
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1432208
- 426 views
Original Research
Published on 23 Oct 2024
Triggered ferroptotic albumin-tocopherol nanocarriers for treating drug-resistant breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1464909
- 766 views
Review
Published on 23 Oct 2024
Establishment of a clinical cancer genetics program for breast cancer in a resource-limited country; challenges and opportunities
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1431985
- 1,338 views
Case Report
Published on 21 Oct 2024
Hepatopulmonary syndrome associated with long-term use of ado-trastuzumab emtansine (T-DM1) for treatment of HER2-positive metastatic breast cancer - a case report and series
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1434492
- 679 views
Original Research
Published on 17 Oct 2024
A risk prediction stratification for non-mass breast lesions, combining clinical characteristics and imaging features on ultrasound, mammography, and MRI
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1337265
- 318 views
Original Research
Published on 16 Oct 2024
HER2-low non-metastatic breast cancer in Qatar—a nationwide retrospective cohort study to evaluate the response to neoadjuvant chemotherapy: a real-world analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1398100
- 666 views
Editorial
Published on 16 Oct 2024
Editorial: Reviews in breast cancer: 2023
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1488263
- 369 views
Systematic Review
Published on 14 Oct 2024
Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1423924
- 738 views
Review
Published on 10 Oct 2024
Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1431418
- 1,166 views